ADVENTRX Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing proprietary product candidates. Its lead product candidate is ANX-188, a rheologic, antithrombotic, and cytoprotective agent in Phase III clinical study, which improves microvascular blood flow and has potential application in treating a range of diseases and conditions,
Time to accumulate on dips.
Sentiment: Strong Buy